Member Info for mysteryguy

Exciting times ahead we may finish at 80 today I'm at the edge of my seat.

@ rampymcrampyface - im smoking some mary jane lol. Dude if it is just a case of patient monitoring then absolutely this will sky rocket 60-80p defo (as i previously mentioned) but i think a trial will be needed.Let's all keep our fingers crossed.

How would FDA saying yes you can sell your drug but you need to provide us more trials/data mean a sudden price surge? perhaps I am missing something here.... also @daytrader how am i speaking of my own desires? ive just stated I am also invested here and off course wish for the best possible outcome but I am just 1) starting my opinion and 2) being realistic.

Looks to me as if a lot of people are confused here. Whatever is released from the minutes meeting with FDA it will not send the SP surging up. It's obviously going to be a trial needed but for those in denial let's say it's my favourite a label change or more data it still has to be actioned by Motif and then approved from the FDA for any significant change in SP.
Realistically we have a chance it could creep to the 20p region within 12months if other ventures go well and financing remains strong, which would allow some to break even (including myself) good luck everyone.

come on where's all the people so quick to defend this company?

Yes well observed. I was typing on my phone and made a typo. Now be honest on my last prediction which turned out to be correct I called you out after your silly 'Afternoon members' post and you were hidding. Seems like you and some others take other people's comments to heart and are in denial. This company is not a good performer and as ive said a million timea before the only people making a killing here are the market makers. Soon as I break even i am out.

@sankeys didnt I embbaress you last time?

Soon as I break even i am out. Even if i was at even now I cant bring myself to get excited about its up and down movememt resulting in no difference at the end

You talk like you're a chav so due to that I won't be responding to your messages now vanish....lol

@liquid1 - I sincerely hope so obviously as i am invested here too. But it depends what news, if trials arre mentioned do you think it's going to send this into double digits? not trying to sound pessimistic. I am just trying to see logic here.

This will close today on low 8's and will then fluctuate between high 7's and Low 8's tomorrow before settling back to its comfortable price. Currently this Share's comfortable price based on it's current situation is 6-7p.
If the inevitable is confirmed that trials are required this could cause a momentary crash to 5p before (hopefully) going back up again.

IM ALWAYS BAFFLED AT THE HYPE THIS COMPANY GENERATES.

unlikely as they would have submitted all the data they had to the FDA. More then likely will require a trial of some sort but hopefully not a big one. fingers crossed

I don't think we've been in the 1.60's since February before the license extension was announced and since then something was keeping this share 50% above it's average. We were consistent around the 1.80-2.10 region.

we are still above average however slightly worrying now.

Is that it then?

as mentioned in the below article released in March. estimate time frame is 6-12months so minimum September-October so not quite the end for now. Personally if no deal is done this year. I think it's unlikely to ever happen. there second license extension is determined by the first and given the time frame to commence drilling by start 2020. It really all falls don to 2019.

http://www.tribune242.com/news/2019/mar/18/oil-explorers-254m-certainty-weve-craved/

BPC, in a presentation to investors just prior to last week’s capital raising, promoted its progress in resolving “above ground issues” relating to its licence extension and exploratory well drilling obligations as paving the way for further investment in the company.

#It added that rising oil prices, and a renewed industry focus on exploration, had enhanced BPC’s prospects of finding a joint venture partner - a search it estimated to investors would conclude in the “next six to 12 months”.

Due to the rejection on 14th of Feb, should we get approval this time around I would estimate anywhere in the 60-80p region as opposed to the projected £1 prior to the FDA rejection.

However and I have to say this but in my view it seems extremely unlikely FDA will approve for the ABSSSI route. Hence why they have looked at other avenues to launch Iclaprim. Raising funds to keep afloat is now the next big issue they face.

What's your break even out of interest?

Erm lol yes they are, in terms of Crude Oil. here is 5 articles confirming this. Let me know if you need more proof dip****

https://www.eia.gov/todayinenergy/detail.php?id=37053

https://money.cnn.com/2018/09/12/investing/us-oil-production-russia-saudi-arabia/index.html

https://www.washingtonpost.com/gdpr-consent/?destination=%2fpolitics%2f2019%2flive-updates%2ftrump-white-house%2flive-fact-checking-and-analysis-of-trumps-2019-state-of-the-union-address%2fthe-u-s-is-the-largest-global-crude-oil-producer%2f%3f&utm_term=.d88383a3ae0a

https://247wallst.com/energy-economy/2019/01/18/us-to-be-worlds-largest-oil-producer-in-2019/

https://uk.reuters.com/article/us-usa-oil-eia-outlook/eia-raises-forecast-for-2019-u-s-crude-output-growth-idUSKCN1RL2C8

Chances look slim. not the best times for oil companies at the moment. Heightened tension between Iran and the USA would normally cause oil prices to surge however it has had little effect in fact it's going down slightly.
USA are now the worlds largest oil produces and have a market dominance.

People like me who purchased at 1p have little to loose worst comes to worst we break even and call it a day. Those who bought at the higher end 1.80-3.00 have more of a gamble and unless it's money you can afford to loose I would be sceptical. But off course do your own research and go with your gut not your heart.

Which of Motif's new ventures to people feel will be more successeful. It's partnership with Lamenar or with the German University? Or are people still in denial

Would love to hear feedback from the more experienced investors here